EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow

Vera M Witjes, Dorien M A Hermkens, Julie E M Swillens, Yvonne H C M Smolders, Marian J E Mourits, Margreet G E M Ausems, Joanne A de Hullu, Marjolijn J L Ligtenberg, Nicoline Hoogerbrugge

Familial Cancer · 2024

DOI: 10.1007/s10689-024-00398-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Familial Cancer, 2024. Verfasst von Vera M Witjes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Workflow, Genetic Testing, Genetic Predisposition to Disease, Ovarian Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic testing in patients with ovarian carcinoma (OC) is crucial, as around 10–15% of these women have a genetic predisposition to OC. Although guidelines have recommended universal germline testing for all patients with OC for a decade, implementation has proved challenging, thus resulting in low germline-testing rates (around 30–50%). Many new initiatives to improve genetic-testing rates have emerged, but most have been carried out at the local level, leading to differences in workflows within and between countries. We present an example of a nationwide implementation project that has successfully led to a uniform, high-quality genetic-testing workflow for women with OC. Nationwide multidisciplinary meetings generated consensus on the preferred workflow for OC genetic testing: the “Tumor-First” workflow. This workflow means starting by testing the tumor DNA for the presence of pathogenic variants in OC-risk genes, thus providing a prescreen to germline testing while yielding information on the effectiveness of treatment with PARP inhibitors. This new workflow efficiently stratifies genetic counseling and germline testing and reduces healthcare costs. Although challenging, the nationwide implementation of this workflow was successful, resulting in tumor-DNA testing rates exceeding 80%. In this article, we present our structured implementation approach, illustrate our implementation strategies—which were tailored to identified factors important to implementation—and share the lessons learned from the Tumor-First implementation project. This knowledge could facilitate the future implementation of workflows aimed at optimizing the recognition of hereditary cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WorkflowGenetic TestingGenetic Predisposition to DiseaseOvarian NeoplasmsCarcinoma, Ovarian EpithelialHumansFemaleGenetic CounselingGerm-Line Mutation

Stichwörter der Autor:innen

BRCAEpithelial ovarian cancerHeredityImplementationInnovationMultidisciplinary

Autor:innen und Institutionen

  • Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • IQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands.

Förderung

  • KWF Kankerbestrijding

Zitieren

APA

Witjes, V. M., Hermkens, D. M. A., Swillens, J. E. M., Smolders, Y. H. C. M., Mourits, M. J. E., Ausems, M. G. E. M., de Hullu, J. A., Ligtenberg, M. J. L., & Hoogerbrugge, N. (2024). Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow. Familial Cancer. https://doi.org/10.1007/s10689-024-00398-9

Vancouver

Witjes VM, Hermkens DMA, Swillens JEM, Smolders YHCM, Mourits MJE, Ausems MGEM, et al. Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow. Familial Cancer. 2024. doi:10.1007/s10689-024-00398-9

BibTeX
@article{Witjes2024,
  author = {Witjes, Vera M and Hermkens, Dorien M A and Swillens, Julie E M and Smolders, Yvonne H C M and Mourits, Marian J E and Ausems, Margreet G E M and de Hullu, Joanne A and Ligtenberg, Marjolijn J L and Hoogerbrugge, Nicoline},
  title = {Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow},
  journal = {Familial Cancer},
  year = {2024},
  doi = {10.1007/s10689-024-00398-9}
}
Kostenlos starten →